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1. Introduction
Gastric cancer (GC) is one of the leading 
causes of cancer-related deaths.[1] Its onset 
and progression are commonly associated 
with the infection by the Gram-negative 
bacterium Helicobacter pylori. Approxi-
mately half of the World’s population is 
colonized with this bacterium, however, 
the majority of the individuals are asymp-
tomatic.[2] The long-term infection with H. 
pylori in combination with other factors, 
such as genetic background and dietary 
habits, among others, can potentiate gas-
tric carcinogenesis.[3] The most severe 
GC outcomes are usually related with 
the translocation of the cytotoxin-associated gene A antigen 
(CagA) from the H. pylori to the host epithelial cells through 
the cag pathogenicity island (PAI).[4] The presence of the onco-
protein CagA in the epithelial cell membrane and its phos-
phorylation induce an elongation of epithelial GC cells to an 
“hummingbird”-like shape that is usually associated with the 
epithelial mesenchymal transition (EMT).[5] In EMT the epithe-
lial cells gain a mesenchymal character, lose cell-cell contacts 
and increase their migration and invasive capacity.[6]
Hyaluronic acid (HA) is one of the most abundant glycosa-
minoglycans (GAGs) in the extracellular matrix (ECM). Struc-
turally, this is the simplest GAG as it is composed by repeating 
disaccharides of N-acetylglucosamine and glucuronic acid. 
Besides this simple composition, HA is involved in different 
signaling pathways and thus, able to modulate pathological and 
physiological processes. An example is cancer cell behavior, 
which depends on HA size: short HA (<100 kDa) is linked to 
cancer progression and poor GC prognosis;[7] while long HA is 
associated with cancer latency.[8] The main cell surface receptor 
for HA, the transmembrane protein CD44, is also a GC stem 
cell marker associated with cancer cell proliferation.[9] Con-
sidering these HA bioactivities, we developed a 2D platform 
to assess the impact of HA size on the formation of an inva-
sive “hummingbird” phenotype on the AGS cell line (derived 
from a GC). We built layer-by-layer (LbL) constructs through 
the sequential deposition of five bilayers made of poly-l-lysine 
(PLL, a polycation) and HA (a polyanion) of different sizes.[10] 
In all generated constructs, (PLL–HA)5, the final surface-
exposed layer is made of HA. GC cells were seeded on these 
constructs and the influence of the HA size on the transition to 
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the “hummingbird” phenotype and its link to GC invasiveness 
was investigated.
2. Results and Discussion
2.1. Hummingbird Phenotype in the Presence of HA of Low Mw
To evaluate the influence of the HA’s molecular weight (Mw) 
on the cellular morphology we cultured AGS cells on the 
(PLL–HA)5 LbL constructs generated using HA of 5.6, 618, and 
1450  kDa (Figure  1). We observe clear morphological differ-
ences between AGS cells cultured on the LbL with the shortest 
HA, i.e., 5.6 kDa, that exhibited a spindle-like shape typical of 
the “hummingbird” phenotype[5a, 11] and the other constructs 
presenting HA of higher Mw (Figure 1A) for which round cells 
were observed (Figure 1B). Of note, multinucleated giant cells 
(MGC), typical for AGS cultures, were observed on the control 
surface (i.e., tissue culture polystyrene, TCPS).[12]
The number of adherent cells was also different: signifi-
cantly more cells adhered on the (PLL–HA)5 presenting HA of 
5.6  kDa when compared to the constructs presenting longer 
HA chains (Figure  1C). These results clearly demonstrate the 
distinct effect of the shortest HA (5.6  kDa) on AGS cells: it 
induces changes in cell morphology, into a spindle-like shape 
and maintains the high cell proliferation level, as confirmed by 
Ki-67 staining (Figure S1, Supporting Information).
2.2. Different Mechanotransduction Induced by the LbL Constructs
The use of HA with different sizes affect the mechanical 
properties of the LbL constructs, as previously demonstrated 
in detail.[13] Cells can sense these differences via a process 
called mechanotransduction.[14] We measured the surface 
stiffness of the constructs as a function of the HA’s size 
(AFM nanomechanical mapping) and observed that the 
shorter HA forms stiffer layers (Figure  2B–C) a result that 
is consistent with the enhanced hydration capacity of longer 
HA.[15]
Yes-associated protein (YAP) is typically involved in the 
transduction of mechanical cues.[16] In cancer, the increased 
expression of YAP together with its nuclear translocation is 
associated with tumor growth and metastasis.[3,17] We observed 
that cells cultured on softer surfaces, i.e., (PLL–HA)5 of 618 and 
1450  kDa, express YAP mainly in the cytoplasm (Figure  2A). 
YAP translocation to the nucleus occurred in cells seeded on 
the stiffer surface, i.e., (PLL–HA)5 of HA 5.6 kDa (Figure S2A, 
Supporting Information). This translocation is usually associ-
ated with the formation of stress fibers that flattens the nucleus 
to the substrate.[18]
Surface stiffness can also modulate the cell’s migration pat-
tern. We used time-lapse live cell imaging to determine the 
cellular paths and distances. AGS cells cultured on stiffer sub-
strates, i.e., TCPS and (PLL–HA)5 containing HA of 5.6  kDa 
presented the longest cell paths (Figure  2B; Figure S3, Sup-
porting Information). However, the morphology of the cells 
cultured on these substrates is significantly different as dem-
onstrated by the determined aspect ratio (AR) (Figure  2C; 
Figure S2B, Supporting Information): round cells were 
observed on TCPS and (PLL–HA)5 surfaces generated with HA 
of high Mw (Figure S2C, Supporting Information), while cells 
with spindle-like morphology was induced by the substrates 
presenting HA of 5.6 kDa showing that the mechanotransduc-
tion is not the only factor that influence this morphological 
transition.
Figure 1. Transmission light microscopic images showing the morphology A) of AGS cells seeded on the LbL surfaces presenting HA of different Mw, 
i.e., 5.6, 618, and 1450 kDa. Morphometric analysis B) and number C) of the cells cultured under the same experimental conditions as in (A). Scale 
bars correspond to 100 µm. The data presented in the graphics correspond to the mean ± SD calculated from a sample size of n ≥ 25. Statistical 
significance was calculated using the Mann–Whitney test. Statistical differences are marked with *** for p < 0.001, ** for p < 0.01, and * for p < 0.05.
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2.3. HA Mw Modulates the Expression of CD44 and RHAMM 
Receptors
CD44, the major cell surface receptor for HA, is a cancer stem 
cell marker that is overexpressed in GCs.[19] AGS cells cultured 
on (PLL–HA)5 expressed more CD44 when compared with 
cells on TCPS and this difference is more pronounced for the 
constructs containing HA of higher Mw (Figure  3A–C). Such 
increment of the CD44 expression as a function of the HA size 
is in good agreement with our previous results obtained with 
bilayered constructs.[8] Of note, whereas the CD44 protein level 
increases with the HA Mw, the mRNA level shows an oppo-
site trend (Figure  3B). This observation can be explained by: 
1) the long protein life-time that gets accumulated over time, 
while mRNA turnover is fast; and/or 2) mismatch between the 
mRNA and protein levels, due to the temporal delay between 
post-translation of mRNA and protein expression.[20]
CD44 expressed by AGS cells seeded on TCPS is mainly 
located in the cytoplasm. When cells are in contact with the 
substrate containing HA, i.e., LbL constructs, CD44 is recruited 
to the cells’ surface (Figure 3A, white arrows) regardless of the 
HA size.
RHAMM is another HA receptor that is expressed only 
during tissue remodeling and in pathological scenarios. As 
an example, overexpression of RHAMM in cancer promote 
an invasive phenotype[21] and its colocalization with actin is 
associated with increased cellular motility.[22] RHAMM can 
be localized in different cellular compartments and its role 
depends on the localization: intracellular RHAMM promotes 
cell polarity and migration, and regulates the microtubule 
dynamics[23] through the interaction with phosphorylated 
ERK1/2 protein (i.e., p-ERK1/2), while nuclear RHAMM colo-
calize with p-ERK1/2, controlling gene expression responsible 
for cellular motility.[24] Additionally, RHAMM can play dif-
ferent extracellular functions; however, despite its ability to 
interact with HA, it lacks a link module for HA binding. In 
this context, RHAMM usually interacts with CD44 to form 
CD44/RHAMM–HA complexes. Of note, RHAMM present 
on the cell surface is able to activate HA-dependent signaling 
pathways associated with cells migration and tumor invasion/
motility through the regulation of Ras, ERK1/2 and Src.[23b,25] 
RHAMM was expressed by AGS cells cultured on different 
LbLs (Figure  3C; Figure S4A, Supporting Information) but 
its localization depends on the HA’s Mw: AGS cells cultured 
on (PLL–HA)5 presenting HA of 5.6 kDa have RHAMM local-
ized in the nucleus (Figure 3A, blue arrows) and in the cyto-
plasm, while cells cultured on the surfaces presenting HA of 
1450 kDa lack nuclear RHAMM (Figure 3A; Figure S4B, Sup-
porting Information). The immunostaining also revealed that 
AGS cells cultured on LbL with short HA, 5.6 kDa, colocalized 
RHAMM and actin (Figure  3A) and indeed, this is the sub-
strate that promote higher cellular motility (Figure  2B). On 
Figure 2. Confocal microscopy images showing the immunofluorescence of YAP protein. Scale bars correspond to 20 µm A). Young’s modulus versus 
distance B) and Young’s modulus versus aspect ratio C) of AGS cells cultured on LbL constructs presenting HA of different sizes. Data presented in 
the graphics correspond to the mean ± SD.
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the other hand, the nuclear RHAMM and nuclear p-ERK1/2 
are present in AGS cells seeded on the same substrates). The 
proliferation, migration and invasion of cancer cells are often 
associated with the activation of the ERK1/2 signaling pathway, 
and their nuclear translocation is a hallmark for cancer aggres-
siveness, as observed for the surfaces presenting HA of 
5.6 kDa.[26]
2.4. HA Regulates the Downstream Signaling Pathways 
Associated with Cancer Migration
Tissues infected with H. pylori overexpress Annexin 4 (ANX4).[27] 
ANX4 is a protein predominantly expressed in epithelial cells. 
Its overexpression is a hallmark of the development of different 
epithelial tumors, such as the gastric adenocarcinoma. ANX4 is 
involved in the regulation of downstream signaling cascades, 
such as the activation of AKT pathway associated with the 
proliferation and migration of cancer cells as well as with the 
tumor aggressiveness.[28]
AGS cells have high expression of ANX4 as shown by the 
results obtained for the cells cultured on TCPS (Figure 4). Such 
high expression is consistent with the malignant phenotype 
of this cancer cells. A similar observation has been reported 
to the infected tissues by H. pylori.[29] An inhibition of ANX4 
expression and the reduction of the activated form p-AKT was 
observed in AGS cultures on the LbLs, especially when con-
structs presenting HA of higher Mw, i.e., 618 and 1450  kDa 
were used as substrates (Figure  4). In contrast, the malignant 
phenotype associated with the high expression of ANX4 and the 
p-AKT pathway is maintained on the surfaces presenting HA of 
5.6 kDa. The overexpression of ANX4 has been reported to be 
correlated with an upregulation of RHAMM.[30] However, our 
results show that the increment of the HA’s Mw is accompanied 
by an increase in RHAMM expression both at the protein and 
mRNA levels (Figure 3C; Figure S4A, Supporting Information). 
Of note, it is known that CD44 binds to all sizes of HA, while 
RHAMM preferentially binds to HA of low Mw (i.e., <7 kDa).[31] 
This preferential binding of RHAMM to low Mw HA could be 
one of the reasons for the maintenance of the malignant phe-
notype. In fact, we observe the recruitment of RHAMM to the 
cell’s membrane in the presence of HA of 5.6 kDa (Figure S4C, 
Supporting Information, using nonpermeabilized cells).
Our results are consistent with a dual effect of HA on the 
invasiveness of GC, under HA’s size-mediated pathways. The 
HA of 5.6 kDa recruits CD44 to the cell surface and stimulates 
the synthesis of de novo CD44, which could be associated with 
the stemness behavior of AGS cells. In addition, the presence of 
Figure 3. Fluorescence images showing AGS cells cultured on TCPS and (PLL–HA)5 of different Mw immunostained for CD44 (white arrows indicate 
CD44 at the membrane) and for RHAMM (blue arrows show nuclear localization of RHAMM). Scale bars correspond to 20 µm A). CD44 gene expres-
sion on AGS cells seeded on the same LbL surfaces B). Western-blot analysis of CD44 (120 kDa) and RHAMM (90 kDa) after 3 days of cell culture 
C). The data presented in the graphics correspond to the mean ± SD and were calculated from a sample size of n = 2.
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RHAMM in the cell membrane could be correlated to the for-
mation of CD44/RHAMM–HA complexes with HA of 5.6 kDa 
triggering the elongated shape which is characteristic for inva-
sive cells and agrees with the protein expression of p-ERK1/2, 
ANX4, and p-AKT confirming the invasive phenotype of these 
cells.[4a] In contrast, long HA (of 1450  kDa) recruits CD44 to 
the cell surface but does not trigger de novo CD44 synthesis. 
In addition, an inhibition of ANX4 accompanied by a reduced 
expression of p-AKT is also observed (Figure 4B). AGS attach-
ment to (PLL–HA)5 containing HA of 1450  kDa induces a 
decreased migration, while invasive pathways are downregu-
lated, being consistent with a promotion of cancer latency by 
long HA (Figure 5).[31]
3. Conclusion
We demonstrated that HA of different sizes can induce dis-
tinct cancer cell behavior. AGS GC cells displayed increased 
polarity and morphometric changes associated with the inva-
sive “hummingbird” phenotype in the presence of short HA, 
i.e., 5.6 kDa. We further demonstrated that long HA, i.e., HA of 
1450 kDa, inhibits the migration of AGS cells, being consistent 
with the promotion of less migrating cell phenotype. In con-
clusion, we show that the developed LbL surfaces are relevant 
model systems that can be used to study cancer cell behavior, 
in particular the different signaling cascades involved in HA-
mediated cancer cell migration and invasion.
4. Experimental Section
Materials: HA sodium salts of 5.6  kDa, 618  kDa (HA700K-5), 
and 1450  kDa (HA15M-5) (Mw was determined by GPC as detailed 
below) were purchased from Lifecore (USA) and poly-l-lysine (PLL) 
hydrobromide (P2636) was acquired from Sigma-Aldrich. N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, 
≥98.0%) and N-hydroxysuccinimide (NHS) were purchased from Sigma-
Aldrich. The reagents were used as received without further purification.
Gel Permeation Chromatography (GPC): GPC measurements were 
performed using a Malvern Viscotek TDA 305 with refractometer 
(RI-Detector 8110, Bischoff), right and low angle light scattering (LS), 
and viscometer detectors on a set of four columns: precolumn Suprema, 
5 µm, 8 × 50, Suprema 30 Å, 5 µm, 8 × 300, and 2x Suprema 1000 Å, 
5 µm 8 × 300. The system was kept at 30 °C. PBS buffered saline (0.01 
m phosphate buffer, 0.0027 m potassium chloride and 0.137 m sodium 
chloride, pH 7.4, at 25 °C, Sigma-Aldrich) and 0.05% (w/v) NaN3 were 
used at a rate of 1  mL min−1. The absolute Mw was determined by a 
calibration of the RI and LS detectors performed using the software 
Omnisec 5.12 (ViskoteK) with a pullulan of Mn 48.8 kDa and PDI 1.07. 
The dn/dc of HA was taken from the literature.[32] The chromatograms 
are presented in Figure S6 (Supporting Information).
Layer-by-Layer Film Construction: The LbL constructs were build-up 
on tissue culture polystyrene (TCPS) coverslips of 13 mm  diameter 
by alternate dipping, for 10 min, into a solution of PLL (0.5  mg mL−1 
in NaCl 0.15 m) and in a solution of HA (1  mg mL−1 in NaCl 0.15 m) 
containing the crosslinker EDC (400 × 10−3 m) and NHS (100 × 10−3 m). 
After each layer deposition, the substrate was washed for 10 min with 
NaCl 0.15 m at pH ≈ 6.0–6.5. The sequential layer deposition was 
repeated ten times generating a (PLL–HA)5 film. The final constructs 
were washed with water and sterilized under UV light for 30 min prior 
cell seeding.
Cell Seeding and Immunocytochemistry Analysis: AGS cells (a 
hyperdiploid middling differentiated human gastric adenocarcinoma cell 
line derived from a tumor resected from the stomach of a 54 year old 
Caucasian female), at passage 6, were expanded in RPMI-1640 medium 
(Sigma-Aldrich, Portugal) supplemented with 10% of fetal bovine serum 
(FBS, Gibco) and 1% antibiotic/antimycotic solution (final concentration 
of penicillin 100 units mL−1, streptomycin 100 mg mL−1 and 25 µg mL−1 
amphotericin B; Gibco, UK) and incubated at 37 °C  in the presence of 
Figure 5. Schematic representation of the proposed mechanisms (and 
signaling pathways) promoted by the HA of different Mw.
Figure 4. Western-blot analysis and the respective densitometry showing the expression of ANX4 (35 kDa) and p-AKT (62 kDa) by the AGS cells cultured 
on the different LbLs. The data presented in the graphics correspond to the mean ± SD and were calculated from a sample size of n = 3. Statistical 
significance was calculated using the Mann–Whitney test. Statistically differences are marked for p < 0.05, in comparison to the control (TCPS).
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5% CO2 until reaching confluence. Cells were harvested with TrypLE 
and seeded (11 000 cells cm−2) on the TCPS (control) and (PLL–HA)5-
coated TCPS for 3 days. For immunostaining, cells were washed with 
PBS, fixed with 10% buffered formalin, followed by permeabilization with 
0.2% Triton X-100 in PBS for 5 min. Cells were blocked with 3% BSA in 
PBS for 30 min  at room temperature and the monoclonal antibody to 
CD44 (AM06286SU-N from ACRIS) was used at a 1:400 dilution in 1% 
BSA in PBS (w/v) for 1 h at room temperature. The rabbit antimouse 
Alexafluor-488 (1:500 dilution, 1% BSA in PBS (w/v)) was used as a 
secondary antibody. For the staining of nuclei and actin, DAPI (1:500 
dilution in 1% BSA in PBS (w/v)) and Phalloidin-TRITC (1:250 dilution, 
1% BSA in PBS (w/v)) were used, respectively. RHAMM was stained 
with RHAMM (H-8) mouse monoclonal antibody (1:400 dilution) and 
for YAP a human antimouse antibody was employed (SC-101199; 1:500 
dilution, 1% BSA in PBS), followed by the secondary rabbit antimouse 
Alexafluor-488 (1:500 dilution, 1% BSA in PBS) for both primary 
antibodies. Stained cells were observed under confocal laser scanning 
microscope (TCS SP8, Leica, Germany).
Real-Time qPCR: Total RNA was extracted from AGS cells seeded on 
(PLL–HA)5 coated T25 culture flasks. Briefly, after 3 days of culture the 
flasks were washed with PBS, the TRI reagent (Sigma-Aldrich, USA) was 
added, and the flask was gently scratched to remove the cells from the 
bottom. The cells were stored at −80 °C. After the removal of proteins by 
chloroform extraction, the RNA pellet was washed with isopropyl alcohol 
and ethanol (70%). The RNA pellet was rebuilt in RNAse-free water 
(Gibco, Invitrogen, UK). Reverse transcriptase (RT)-PCR was performed 
according to the protocol from the iScript cDNA synthesis kit (QuantaBio, 
Gaithersburg, MD, USA). The transcripts’ expression data were normalized 
with the housekeeping gene 18S and the relative quantification calculated 
according to the Livak (2_ΔΔCT) method using the cells seeded on TCPS 
as the calibrator. The CD44 (all isoforms) and RHAMM gene expression 
was evaluated using the primers presented in Table 1.
Cells Migration through Time-Lapse Analysis: After 24 h of incubation, 
the cells seeded on the different surfaces were analyzed using an 
inverted microscope (Zeiss Axio Observer, Germany) equipped with a 
temperature (37 °C)  and CO2 control device (5% CO2). Images of the 
cells (20× objective) were continuously captured every 5 min  for 16 h 
using the Zen software (Zeiss, Germany). Image stacks and cellular 
displacement were analyzed with the Fiji software (http://fiji.sc/wiki/
index.php/Fiji) using the Manual Tracking Plugin.
Western-Blot Analysis: AGS protein lysates were extracted in RIPA 
buffer (150 × 10−3 m NaCl, 1% Triton-X100, 0.5% sodium deoxycholate, 
0.1% sodium dodecyl sulphate, 50 × 10−3 m  Tris-Base, pH = 8) 
supplemented with 1x Protease (cOmplete, ROCHE) and 1x Phosphatase 
(PhosSTOP, ROCHE) inhibitor cocktails for 30 min with 5 min intervals 
of vortexing. The extracts were centrifuged (18 000 × g, 16 min, 4 °C), and 
the supernatant was further analyzed by Western-blotting. The proteins 
in the Laemmli buffer were denatured at 37 °C for 1 h and 30 min and 95 
°C for 5 min prior to use. The lysates containing 40 μg of protein were 
resolved using 4–12% Bis-Tris Protein Gels (Novex) and transferred to 
nitrocellulose membranes (Thermo Fischer Scientific). The membranes 
were incubated in 4% (m/v) BSA in Tris-buffered saline-Tween (TBS-T, 
Cell Signalling Technology) and probed with α-smooth muscle actin 
(rabbit monoclonal [E184], 1:5000 dilution), p-AKT (rabbit monoclonal 
antibody [EP2109Y], 1:1000 dilution), AKT (rabbit monoclonal antibody 
(B-1), 1:1000 dilution), RHAMM (mouse monoclonal antibody (H-8), 
1:1000 dilution), p-ERK1/2 (rabbit monoclonal antibody, 1:1000 dilution), 
CD44 (rabbit monoclonal antibody, 1:1000 dilution), and Annexin-4 
(rabbit monoclonal antibody, 1:1000 dilution). After three cycles of 
5 min  washing with TBS-T, the membranes were incubated with 
IRDye800CW antirabbit or antimouse (1:10 000 dilution) for 1 h and 
imaged on the Odyssey Infrared Imaging System (LI-COR Biosciences).
Statistical Analysis: The data were graphically presented as mean 
± SD and the statistical analysis was performed for a sample size (n) 
≥3. The Shapiro–Wilk test was used to evaluate the normality of the 
distribution of the data (p < 0.05). The Kruskal−Wallis test followed by 
the Mann–Whitney test was applied when the data showed non-normal 
distribution. Significant variations are considered with *** for p  < 
0.001, ** for p < 0.01, and * for p < 0.05. Graphical representation and 
statistical analysis were performed on GraphPad Prism 7.0 Software.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
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